Can Corcym transform surgical heart valve replacement? Why DeviceTalks Minnesota was nice!

DeviceTalks Podcast Network

In this podcast episode, MassDevice Editor Chris Newmarker sits down with Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since it became an independent company under Gyrus Capital in 2021.

Next up is an effort to expand innovation beyond Corcym’s core heart valve portfolio to areas such as heart failure treatment. Mazzi, though, still has a lot to say about surgical heart valve replacement when speaking with MassDevice Editor in Chief Chris Newmarker. Surgical heart valve procedures are shifting toward being more laparoscopic, and surgical robotics applications are on the horizon. Even as transcatheter heart valves generate a lot of buzz in medtech, surgical heart valve innovation is getting exciting, too. Like the Arthurian heroes that Corcym names its products after, Mazzi and his company are on a quest.

But first Host Tom Salemi, DeviceTalks Managing Editor Kayleen Brown and Newmarker share their highlights of the wildly successful DeviceTalks Minnesota that took place on June 11. Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. https://devicetalks.castos.com/subscribe